Difference between revisions of "Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 12 in DOI: 10.1016/j.clim.2020.108427 (Q11255)"
Jump to navigation
Jump to search
(Created claim: Fourteenth Author string (P162): Chabriere E, #quickstatements; #temporary_batch_1593104579448) |
(Created claim: Volume (P103): 105949, #quickstatements; #temporary_batch_1593105601776) |
||
| (5 intermediate revisions by the same user not shown) | |||
| Property / Fifteenth Author string | |||
| + | La Scola B | ||
| Property / Fifteenth Author string: La Scola B / rank | |||
| + | Normal rank | ||
| Property / Sixteenth Author string | |||
| + | Rolain JM | ||
| Property / Sixteenth Author string: Rolain JM / rank | |||
| + | Normal rank | ||
| Property / Seventeenth Author string | |||
| + | Brouqui P | ||
| Property / Seventeenth Author string: Brouqui P / rank | |||
| + | Normal rank | ||
| Property / Eighteenth Author string | |||
| + | Raoult D | ||
| Property / Eighteenth Author string: Raoult D / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (English) | ||
| Property / title: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (English) / rank | |||
| + | Normal rank | ||
| Property / Volume | |||
| + | 105949 | ||
| Property / Volume: 105949 / rank | |||
| + | Normal rank | ||
Latest revision as of 17:20, 25 June 2020
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 12 in DOI: 10.1016/j.clim.2020.108427
|
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
|
Statements
Int J Antimicrob Agents
0 references
2020
0 references
Gautret P
0 references
Lagier JC
0 references
Parola P
0 references
Hoang VT
0 references
Meddeb L
0 references
Mailhe M
0 references
Doudier B
0 references
Courjon J
0 references
Giordanengo V
0 references
Vieira VE
0 references
Dupont HT
0 references
Honore S
0 references
Colson P
0 references
Chabriere E
0 references
La Scola B
0 references
Rolain JM
0 references
Brouqui P
0 references
Raoult D
0 references
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (English)
0 references
105949
0 references
